K. Mahajan

Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands

G. Harty, G. Hengstman, K. Schiffers, 2019, Applied Health Economics and Health Policy.

Budget Impact Analysis of Cladribine Tablets in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients in Kingdom of Saudi Arabia

S. Bohlega, O. Mohamed, H. Al-Mudaiheem, 2020 .